Steffen-Sebastian Bolz
Co-Founder, Executive Board Member & Chief Scientific Officer Aphaia Pharma
Steffen-Sebastian Bolz, M.D., Ph.D., is a scientist, physician, and entrepreneur. He is a Co-Founder and Chief Scientific Officer of Aphaia Pharma AG and Founder and Chief Scientific and Medical Officer at Qanatpharma AG. Steffen-Sebastian holds a full professorship at the University of Toronto, is a Principal Investigator at the Ted Rogers Centre for Heart Research, and is Director of the Toronto Centre for Microvascular Medicine. Steffen-Sebastian holds a medical degree and a doctorate from the universities of Lübeck and Munich, Germany.
Seminars
Wednesday 15th April 2026
Reawakening the Body’s Natural Hormone Response Through Precision Gut Signaling to Treat Obesity
2:00 pm
- Restoring the body’s natural metabolic food response by utilizing a proprietary precision-targeted oral formulation designed for release in the distal small intestine
- Activating the endogenous release of a broad spectrum of enteric hormones like GLP-1, GLP-2, and PYY, achieving a physiological response that avoids systemic hormone over-stimulation
- Highlighting clinical trial data showing targeted glucose delivery significantly improves glucose handling and elicits competitive weight loss outcomes while maintaining a benign safety profile
